Join for Free!
112418 members
table of contents table of contents

This article reviews role of saliva in toxicology.

Biology Articles » Toxicology » Oral Fluid in Toxicology » References

- Oral Fluid in Toxicology

1. Navazash H. Methods for collecting saliva. Ann NY Acad Sci. 1993; 694: 72-7.

2. Watanabe S, Dawes C. The effects of different foods and concentrations of citric acid on the flow rate of whole saliva in man. Arch Oral Biol 1988; 33 (1): 1-5.

3. Naazesh M, Mulligan RA, Kipnis V. Comparison of the whole saliva flow rates and much concentrations in healthy cancasion young and aged adults. J Dent Res 1992; 71: 1275-8.

4. Tabak L. In defense of the oral cavity; structure biosynthesis, and functions of salivary mucins. Ann Rev Physiol 1995; 57: 547-64.

5. Lamkin MS, Oppentheim FG. Structural features of salivary function. Crit Rev Oral Biol Med 1993; 4 (34): 251-9.

6. Xu T, Levitz SM, Diamond RD, Oppenhein FG. Anticandidal activity of major human salivary histatins. Infect Imun 1991; 59 (8): 1549-54.

7. Moore S, Calder KAC, Millar NJ, Evans R. Antioxidant activity of saliva and periodontal disease. Free Radic Res 1994; 21: 417-25.

8. Kharb S, Singh V, Ghalant PS, Sharma A, Singh GP. Glutathione levels in health and sickness. Ind J Med Sci 2000; 54: 52-4.

9. Mandel ID. Salivary diagnosis : promises, saliva as a diagnostic fluid. Ann NY Acad Sci 1993; 694: 1-10.

10. Chen, Y.M., Contron, N.M., Whitson, P.A. Long-term storage of salivary cortisol samples at room temperature. Clinical Chemistry 1992; 38: 304.

11. Caddy, B. Saliva as a specimen for drug analysis. In R.C. Basett (Ed.), Advances in analytical toxicology. Foster City: Biomedical publications 1984; 1: 198-254.

12. Paxton, J.W., Donald, R.A. Concentrations and kinetics of carbamazepine in whole saliva, parotid saliva, serum ultrafiltrate, and serum. Clinical Pharmacology and Therapeutics, 1980.

13. Selby, C., Lobb, P.A., Jeffcoate, W.J. Sex hormone binding globuling in saliva. Clinical Endocrinology, 1998; 28: 19-24.

14. Swinkels, L.M.J.W., Hoff van, H.J.C., Ross, H.A., Smals, A.G.H., Benraad, T.J. Concentrations of salivary testoterone and plasma total, non-sex-hormone-binding globulin-bound, and free testosterone in normal and hirsute women during administration of dexamethasone synthetic corticotropin. Clinical Chemistry, 1991; 37: 180-5.

15. Wade, S.E. An oral-diffusion-sink device for extended sampling of multiple steroid hormones from saliva. Clinical Chemistry, 1992a, 38: 1878-82.

16. Cone, E.J., Weddington, W.W. Prolonged occurrence of cocaine in human saliva and urine after chronic use. Journal of Analytical Toxicoloty 1989; 13: 65-68.

17. Gross, S.J., Worthy, T.E., Nerder, L., Zimmermann, E.G., Soares, J.R., Lomax, P. Detection of recent cannabis use by saliva 9-THC radioimmunoassay. Journal of Analytical Toxicology 1985; 9: 1-5.

18. Mally, J., Keszei, C., Cserep, G. Theophylline concentrations in serum, saliva, and cerebrospinal-fluid in patients with essential tremor. Therapeutic Drug Monitoring 1992; 14: 135-7.

19. Benkirane, S., Nicolas, A., Galteau, M.M., Siest, G. Highly sensitive immunoassays for the determination of cotinine in serum and serum and saliva. Comparison between RIA and an avidinbiotin ELISA. European Journal of Clinical Chemistry and Clinical Biochemistry 1991; 29: 405-10.

20. Paxton, J.W. Measurement of drugs in saliva: A review. Methods and Findings in Experimental Clinical Pharmacology 1979; 1: 11-21.

21. Umstead, G.S., Morales, M., McKercher, P.L. Comparison of total, free, and salivary phenytoin concentrations in geriatric patients. Clinical Pharmacy 1986; 5: 59-62.

22. Cai, W.M., Zhu, G.Z., Chen, G. Free phenytoin monitoring in serum and saliva of epileptic patients in China. Therapeutic Drug Monitoring 1993; 15: 31-4.

23. Drehsen, G., Rohdewald, P. Rapid high performance thin layer chromatography of salicylic acid, salicylamide, ethoxybenzamide and paracetamol in saliva. Journal of Chromatography 1981; 223: 479-83.

24. Bardy, A.H., Seppala, T., Salokorpi, T., Granstrom, M.L. Monitoring of concentrations of clobazam and norclobazam in serum and saliva of children with epilepsy. Brain & Development 1991; 13: 174-9.

25. Matin, S.B., Wan, S.H., Knight, J.B. Quantitative determination of enantiomeric compounds. I-Simultaneous measurement of the optical isomers of amphetamine in human plasma and saliva using chemical ionization mass spectrometry. Biomedical Mass Spectrometry 1977; 4: 118-21.

26. Katagiri, Y., Nagasako, S., Hayashibara, M., Iwamoto, K. Salivary excretion of mexilletine in normal healthy volunteers. Journal of Pharmacy and Pharmacology 1991; 43: 513-5.

27. Ben-Aryeh H, Laor R, Szargel R, Gutman D, Non H, Pascal M. Saliva for monitoring of patients with primary affective disorders. Isr J Med Sci 1984; 20: 197-201.

28. Rosenthal E, Hoffer E, Ben Aryeh H, Badarni S, Benderly A, Hemli Y. Use of saliva in home monitoring of carbaniazepine levels. Epilepsia 1995; 36: 72-4.

29. Kankirawatana P. Salivary antiepileptic drug levels in thai children. J Med Assoc Thai 1999; 82: 80-8.

30. Coates JE, Lam SF, McGaw WT. Radioiommunoassay of salivary cyclosporine with use of 125 I - labeled cyclosporine. Clin Chem 1988; 34: 1545-51.

31. Kirk JK, Dupuis RE, Miles MV, Gaddy GD, Mirandamassari JR, Willias DM. Salivary theophylline monitoring; reassessment and clinical considerations. Ther Drug Monit 1994; 16: 58-66.

32. Cone EJ. Salivary testing for drugs of abuse. Ann NY Acad Sci 1993; 694: 91-127.

33. Kidwell DA, Holl and JE, Anthanaselis S. Testing for drugs of abuse in saliva and sweat. J Chromatogr B Biomed Sci Appl 1998;l 713: 111-35.

34. Gross SJ, Worthy TE, Nerder L, Zimmermann EG, Soares JR, Lomax P. Detection of recent cannabis use by saliva 9-THC radioimmunoassay. J Anal Toxicol 1985; 9: 1-5.

35. Isutsu KT, Truelove EL, Bleyer WA, Anderson WM, Schubert MM, Rice JC. Whole saliva albumin of an indicator of stomatitis in cancer therapy patients. Cancer 1981; 48: 1450-4.

36. Repace JL, Jinor J, Bayard S, Emmons K, Hammond SK. Air Nicotine and saliva cotinine as indicators of work place passive smoking exposure and risk. Risk Anal 1998; 18: 71-83.

37. Martin K, Burgen ASV. Changes in the permeability of the salivary gland caused by sympathetic stimulation and by catecholamines. Journal of General Physiology 1962; 46: 225-43.

38. Schramm W, Smith RH, Craig PA. Drugs of abuse in saliva: a review. Journal of Analytical Toxicology 1992; 16: 1-9.

39. McDevitt DG. Comparison of pharmacokinetic properties of beta-adrenoceptor blocking drugs. European Heart Journal 1987; 8 (Suppl. M): 9-14.

40. Rai B, Anand SC, Kharb S. Saliva as a diagnostic tool in medical science: a mini review. IJCB 2006 (in Press).

rating: 3.20 from 5 votes | updated on: 30 Apr 2008 | views: 8307 |

Rate article: